Molecular imaging biomarkers for oncology clinical trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24614222.
- Also identified by DOI 10.2967/jnumed.113.126128.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This "Focus on Molecular Imaging" article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current and future cancer biomarker applications of molecular imaging.
Medical subject headings
- Biomarkers
- Molecular Imaging
- Neoplasms